Ultralife Corporation
ULBI
$7.59
-$0.07-0.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.78% | -10.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.78% | -10.69% | |||
| Cost of Revenue | 7.92% | -8.63% | |||
| Gross Profit | 25.34% | -17.23% | |||
| SG&A Expenses | 55.48% | 3.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.07% | -5.24% | |||
| Operating Income | -414.57% | -114.79% | |||
| Income Before Tax | -482.87% | -257.32% | |||
| Income Tax Expenses | -446.23% | -307.41% | |||
| Earnings from Continuing Operations | -497.67% | -243.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 14.81% | 200.00% | |||
| Net Income | -508.36% | -238.79% | |||
| EBIT | -414.57% | -114.79% | |||
| EBITDA | -149.91% | -72.28% | |||
| EPS Basic | -508.05% | -238.83% | |||
| Normalized Basic EPS | -24.64% | -186.54% | |||
| EPS Diluted | -508.05% | -246.60% | |||
| Normalized Diluted EPS | -24.64% | -186.72% | |||
| Average Basic Shares Outstanding | 0.05% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.05% | -0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||